Lai Seong Hooi
Overview
Explore the profile of Lai Seong Hooi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
1823
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kim D, Lee J, Toyama T, Liyanage T, Woodward M, Matsushita K, et al.
Nephrology (Carlton)
. 2025 Jan;
30(2):e70002.
PMID: 39888116
Aim: Anaemia is a significant complication of chronic kidney disease (CKD). However, its prevalence and treatment patterns in Asia are poorly understood. We sought to quantify prevalence of anaemia and...
2.
Herrington W, Staplin N, Agrawal N, Wanner C, Green J, Hauske S, et al.
N Engl J Med
. 2024 Oct;
392(8):777-787.
PMID: 39453837
Background: In the EMPA-KIDNEY trial, empagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, had positive cardiorenal effects in patients with chronic kidney disease who were at risk for disease progression. Post-trial...
3.
Kam-Tao Li P, Ng J, Cai G, Chen W, Chow K, Fan S, et al.
Kidney Dis (Basel)
. 2024 Oct;
10(5):384-397.
PMID: 39430291
Background: Chronic kidney disease (CKD) continues to be a significant global public health issue. The escalating burden of CKD is probably driven by the aging population and the rising prevalence...
4.
Kim D, Lv J, Hladunewich M, Jha V, Hooi L, Monaghan H, et al.
Kidney Int Rep
. 2024 Jul;
9(7):2168-2179.
PMID: 39081761
Introduction: The therapeutic effects of steroids in immunoglobulin A nephropathy (IgAN) global (TESTING) study reported that methylprednisolone reduces the risk of major kidney events in individuals with IgAN at high...
5.
Mayne K, Staplin N, Keane D, Wanner C, Brenner S, Cejka V, et al.
J Am Soc Nephrol
. 2023 Dec;
35(2):202-215.
PMID: 38082486
Significance Statement: SGLT2 inhibitors reduce risk of kidney progression, AKI, and cardiovascular disease, but the mechanisms of benefit are incompletely understood. Bioimpedance spectroscopy can estimate body water and fat mass....
6.
Herrington W, Harper C, Staplin N, Haynes R, Emberson J, Reith C, et al.
Kidney Int Rep
. 2023 Aug;
8(8):1489-1495.
PMID: 37538810
Introduction: We aimed to assess opportunities for trial streamlining and the scientific impact of adjudication on kidney and cardiovascular outcomes in CKD. Methods: We analysed the effects of adjudication of...
7.
Viecelli A, Teixeira-Pinto A, Valks A, Baer R, Cherian R, Cippa P, et al.
BMC Nephrol
. 2022 Nov;
23(1):372.
PMID: 36402958
Background: A functioning vascular access (VA) is crucial to providing adequate hemodialysis (HD) and considered a critically important outcome by patients and healthcare professionals. A validated, patient-important outcome measure for...
8.
Herrington W, Staplin N, Wanner C, Green J, Hauske S, Emberson J, et al.
N Engl J Med
. 2022 Nov;
388(2):117-127.
PMID: 36331190
Background: The effects of empagliflozin in patients with chronic kidney disease who are at risk for disease progression are not well understood. The EMPA-KIDNEY trial was designed to assess the...
9.
Lv J, Wong M, Hladunewich M, Jha V, Hooi L, Monaghan H, et al.
JAMA
. 2022 May;
327(19):1888-1898.
PMID: 35579642
Importance: The effect of glucocorticoids on major kidney outcomes and adverse events in IgA nephropathy has been uncertain. Objective: To evaluate the efficacy and adverse effects of methylprednisolone in patients...
10.
See Y, Cho Y, Pascoe E, Cass A, Irish A, Voss D, et al.
Kidney360
. 2022 Apr;
1(11):1259-1269.
PMID: 35372875
Background: An autologous arteriovenous fistula (AVF) is the preferred hemodialysis vascular access, but successful creation is hampered by high rates of AVF failure. This study aimed to evaluate patient and...